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The chlamydial protease/proteasome-like activity factor (CPAF) is secreted into the host cytosol
to degrade various host factors that benefit chlamydial intracellular survival. Although the full-
length CPAF is predicted to contain a putative signal peptide at its N terminus, the secretion
pathway of CPAF is still unknown. Here, we have provided experimental evidence that the N-
terminal sequence covering the M1–G31 region was cleaved from CPAF during chlamydial
infection. The CPAF N-terminal sequence, when expressed in a phoA gene fusion construct, was
able to direct the export of the mature PhoA protein across the inner membrane of wild-type
Escherichia coli. However, E. coli mutants deficient in SecB failed to support the CPAF signal-
peptide-directed secretion of PhoA. Since native PhoA secretion was known to be independent of
SecB, this SecB dependence must be rendered by the CPAF leader peptide. Furthermore, lack of
SecY function also blocked the CPAF signal-peptide-directed secretion of PhoA. Most
importantly, CPAF secretion into the host cell cytosol during chlamydial infection was selectively
inhibited by an inhibitor specifically targeting type I signal peptidase but not by a type III secretion-
system-specific inhibitor. Together, these observations have demonstrated that the chlamydial
virulence factor CPAF relies on Sec-dependent transport for crossing the chlamydial inner
membrane, which has provided essential information for further delineating the pathways of CPAF
action and understanding chlamydial pathogenic mechanisms.
INTRODUCTION
Members of the genus Chlamydia share an obligate
intracellular life cycle with a distinct biphasic stage
(Hackstadt et al., 1997). Host inflammatory responses
triggered by chlamydial intracellular survival and replica-
tion are thought to contribute to chlamydia-induced
pathologies (Stephens, 2003). For example, invasion of
and replication in ocular or urogenital epithelial tissues by
Chlamydia trachomatis can trigger inflammatory responses
that may lead, respectively, to either trachoma in the eye
(Mabey, 2008) or urogenital tract complications such as
pelvic inflammatory diseases, ectopic pregnancy and
infertility (Ma ˚rdh, 2004). Infection of respiratory epithelial
cells with Chlamydia pneumoniae not only leads to various
airway inflammatory pathologies but may also exacerbate
pathologies elsewhere, including the vessel wall tissues
(Campbell & Kuo, 2004). Thus, understanding how
chlamydial organisms maintain their intracellular survival
and replication should advance our knowledge of chlamy-
dial pathogenic mechanisms.
Chlamydia has to overcome many obstacles to establish a
successful intracellular infection. First, the infectious
elementary body (EB) has to enter a non-phagocytic
epithelial cell, which is probably achieved by chlamydial
injection of a protein into the host cell to induce
phagocytosis (Clifton et al., 2004). Second, once inside a
host cell, the chlamydia-laden vacuole (also called inclu-
sion) has to prevent fusion with host cell lysosomes
(Eissenberg et al., 1983) when the intravacuolar EB
differentiates into a reticulate body (RB) for biosynthesis
and replication. Third, to grow inside the inclusion,
chlamydial organisms have to import nutrients and
possibly energy from the host cell (Su et al., 2004).
Abbreviations: CPAF, chlamydial protease/proteasome-like activity
factor; CPAFc, CPAF C terminus; CPAFn, CPAF N terminus; DMEM,
Dulbecco’s modified Eagle medium; EB, elementary body; FBS, fetal
bovine serum; HMM, hidden Markov model; HRP, horseradish perox-
idase; mAb, monoclonal antibody; MBP, maltose binding protein; NN,
neural networks; OMV, outer membrane vesicle; RB, reticulate body;
SRP, signal recognition particle.
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of the infected cell while RBs are still undergoing
replication (Fan et al., 1998; Greene et al., 2004; Xiao
et al., 2005). Finally, once the progeny RBs differentiate
back to the infectious EBs, how to safely exit the infected
cell to infect neighbouring cells is another challenge facing
the chlamydial organisms (Hybiske & Stephens, 2007). One
of the chlamydial strategies for dealing with these growth
obstacles is to secrete various proteins into the inclusion
membrane (Li et al., 2008a; Rockey et al., 1995; Rzomp
et al., 2006) and into the host cell cytosol (Zhong et al.,
2001).
Among the chlamydial secreted proteins that can be visu-
alized in the cytoplasm of the infected cells are chlamydial
protease/proteasome-like activity factor (CPAF) (Fan et al.,
2002; Zhong et al., 2001; Zhong, 2009), pgp3 (Li et al.,
2008b), CT621 (Hobolt-Pedersen et al., 2009), Cpn0796
(Vandahl et al., 2005) and Cpn0797 (Dong et al., 2006).
The function of CPAF has been extensively studied (Huang
et al., 2008; Zhong et al., 2001). CPAF is a powerful serine
protease with a water-mediated catalytic triad consisting of
H105, S499 and E558 (Huang et al., 2008), which is capable
of degrading a wide spectrum of host proteins. CPAF
degrades transcription factors such as RFX5 (Zhong et al.,
2000) and USF1 (Zhong et al., 1999), which are required
for activation of antigen presentation genes that may aid in
chlamydial evasion of host immune recognition. CPAF also
digests BH3-only proteins that are responsible for detecting
intracellular stress signals, to potentially help chlamydial
evasion of host cell apoptosis triggered by chlamydial
intracellular growth (Pirbhai et al., 2006). Finally, CPAF
can cleave cytoskeleton proteins to facilitate/promote
chlamydial inclusion expansion and stability (Dong et al.,
2004c; Kumar & Valdivia, 2008). CPAF is synthesized as an
inactive proform and processed into two mature fragments
[designated CPAF N terminus (CPAFn) and CPAF C ter-
minus (CPAFc)] (Dong et al., 2004a). CPAFn and CPAFc
form an intramolecular heterodimer. Both cleavage and
intramolecular dimerization are required for CPAF pro-
teolytic activity (Dong et al., 2004b). Recent crystal struc-
tural data has revealed that a fully active CPAF is a
homodimer of two CPAFn/c heterodimers (CPAFn/
c:CPAFn/c; Huang et al., 2008). Despite the extensive
knowledge about CPAF function and biochemical prop-
erties, it is still unclear how CPAF is secreted from
chlamydial organisms into the host cell cytosol.
The chlamydial genome encodes many of the key
components required for both type II and type III secretion
systems (http://stdgen.northwestern.edu/). There are at
least ten operons coding for chlamydial type III secretion
system-related molecules (Hefty & Stephens, 2007). A
functional chlamydial type III secretion system has been
identified (Fields & Hackstadt, 2000; Fields et al., 2003;
Spaeth et al., 2009) and many effector molecules have been
determined (Betts et al., 2009; Spaeth et al., 2009).
However, increasing studies have shown that the Sec-
dependent pathway may also be required for secretion of
certain chlamydial effectors and that this may be essential
in bacterial pathogenesis (Lee & Schneewind, 2001; Pugsley
et al., 1990, 2004). Generally, proteins with N-terminal
signal peptides are substrates secreted by the Sec-dependent
pathway (Stathopoulos et al., 2000). The cytosolic pre-
cursor proteins are recognized by either the secretion-
dedicated chaperone SecB (Francetic & Kumamoto, 1996;
Zhou & Xu, 2005) or the signal recognition particle (SRP)
that can act as a GTP-dependent chaperone and target
the substrate to a SecYEG translocase complex in the cyto-
plasmic or inner membrane (Baba et al., 1990; Collinson,
2005) for access to the periplasmic space (Collinson, 2005;
Driessen & Nouwen, 2008; Economou, 1999). SecY is
absolutely required for the translocase activity while SecE
and SecG are auxiliary molecules (Saier, 2006). An ATP-
dependent motor protein SecA is associated with the
SecYEG complex on the cytoplasmic side to promote the
access of the chaperone-assisted substrate proteins to the
inner membrane SecYEG complex. After crossing the inner
membrane, the N-terminal signal peptides are cleaved
by signal peptidases LepB or LspA so that the substrate
protein can be fully released into the periplasm (Dalbey,
1991; Paetzel et al., 2002; Tuteja, 2005). The periplasm-
localized substrate protein can further exit the bacterial
organisms by passing through the outer membrane via the
type II machinery formed in part by the general secretion
protein D (GspD). Other Gsps such as GspE and GspF may
help the periplasmic substrate protein engage the outer
membrane GspD pore (Lee & Schneewind, 2001). The
chlamydial genome encodes many homologues of the key
components required for a functional type II secretion
pathway (http://stdgen.northwestern.edu/). The chlamydial
homologue of the essential translocase subunit SecY is
encoded by the C. trachomatis ORF CT510; the homologue
of SecF is CT448. Although there is no SecB homologue,
chlamydia does encode many general chaperones including
three GroELs (CT110, CT604 and CT755; Karunakaran
et al., 2003). Some of these chaperones may help secretion
by interacting with two chlamydial homologues of SecA
(CT141 and CT701) to bring the substrate protein to the
chlamydial SecYEG translocon. In addition, the chlamydial
FtsY (an SRP receptor-like protein) may act as a GTP-
dependent chaperone that promotes interaction between
the substrate protein and the SecYEG translocon. The
chlamydial homologues of signal peptidases LepB and
LspA are CT020 and CT408, respectively. Finally, the
chlamydial homologue of GspD (CT572) is predicted to
form an outer membrane pore that facilitates secretion of
periplasmic substrate proteins out of the chlamydial organ-
isms. The chlamydial homologues of GspE and GspF
(CT571 and CT570) may further facilitate the extracellular
localization. Thus, chlamydia possesses homologues of all
the key components of the Sec-dependent pathway.
However, there has been no direct experimental evidence
to demonstrate the functionality, probably due to a lack of
genetic tools for manipulating the chlamydial genome or
reagents required for blocking Sec-dependent protein
export.
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signal peptide, there has been no experimental data to
demonstrate the secretion pathway of CPAF. In the current
study, we have provided direct experimental evidence to
identify the CPAF secretion pathway. We have found that
the N-terminal sequence covering the methionine in
position 1 (M1) to glycine in position 31 (G31) is cleaved
from CPAF during chlamydial infection, and the putative
CPAF signal peptide was able to direct the export of a
heterologous substrate protein into the bacterial periplas-
mic space. More importantly, the functionality of the
CPAF N-terminal signal peptide is dependent on both SecB
and SecY as assayed in Escherichia coli. Finally, we found
that CPAF secretion into the host cell cytosol during
chlamydial infection can be blocked by an inhibitor
specifically targeting signal peptidase but not by a type
III secretion system-specific inhibitor. Together, these
observations demonstrate for the first time that the
chlamydial Sec-dependent pathway is functional and that
CPAF secretion requires the Sec-dependent pathway.
METHODS
Cell culture and chlamydial infection. HeLa229 cells (human
cervical epithelial cell line, ATCC) were grown in Dulbecco’s
modified Eagle medium (DMEM; Invitrogen) supplemented with
10% fetal bovine serum (FBS; Atlanta Biologicals) in a humidified
incubator in the presence of 5% CO2. C. trachomatis serovar LGV2
(L2/434/Bu) or D (D/UW-3/CX) were purified and used to infect
HeLa cells as described previously (Zhong et al., 2001). For some
experiments, the culture media were supplemented with 50 mM
compound C1 (ChemBridge) or 10 mM arylomycin C16 (kindly
provided by The Scripps Research Institute; Roberts et al., 2007).
Purification of CPAF from chlamydia-infected cultures for
determining the N-terminal sequence. HeLa cells infected with C.
trachomatis serovar D at an m.o.i. of 5 for 50 h were harvested from
ten T-175 flasks and the cell pellets were lysed in 10 ml MLB lysis
buffer (25 mM HEPES, pH 7.5, 150 mM NaCl, 5% Igepal CA0630,
10 mM MgCl2, 5 mM EDTA, 10% glycerol) with protease inhibitor
cocktails containing 1 mM PMSF, 20 mM leupeptin, 1.6 mM pepstatin
A, 1.7 mg aprotinin ml
21 (all from Sigma). The CPAF-containing
supernatant was collected after centrifugation (20000 r.c.f., 1 h) at
4 uC and incubated for 1 h at room temperature with the mouse
monoclonal antibody (mAb) 100a (anti-CPAFc) that was covalently
cross-linked to protein G Sepharose (GE Healthcare). The antibody
cross-linking was carried out as follows: protein G beads were mixed
with mAb 100a at 4 uC overnight. After washing away the free
antibody molecules with 0.05% Tween 20 (Sigma) in PBS, the bound
antibodies were covalently cross-linked to protein G by incubating in
PBS containing 0.2 M triethanolamine and 6.5 mg ml
21 of the cross-
linker disuccinimidyl suberate (Pierce Biotechnology) at room
temperature for 30 min. Caution was taken not to over cross-link.
Finally, free antibody molecules were washed away with 1 M glycine
in PBS (pH 3.0). After incubating with CPAF-containing supernatant,
the bead complexes were thoroughly washed; the bound CPAF was
eluted by using 2% SDS and was loaded onto a 12% SDS-PAGE gel.
After electrophoresis, the resolved protein bands were blotted onto
Sequi-Blot PVDF membrane (Bio-Rad). To visualize the CPAF
protein bands, the membrane was briefly stained with Coomassie blue
dye. The proCPAF band, migrating at ~68 kDa, and the activated N-
terminal fragment CPAFn band, migrating at ~29 kDa, were excised
for N-terminal sequence analysis by using a commercial service
provided by Alphalyse. A small portion of the precipitated CPAF
sample was also subjected to Western blot analysis with mAb 54b to
identify the N-terminus-containing CPAF bands (see below).
Although a weak band migrating above the proCPAF, which may
represent the precursor CPAF (with the signal peptide), was also
subjected to N-terminal sequencing analysis, no sequence information
was obtained due to inadequate amounts of protein.
Bacterial strains and plasmid construction. E. coli DH5a was
purchased from Invitrogen. E. coli strains DR473 and DRS were
reported previously (Marrichi et al., 2008) and strains JW3584-1,
MC4100 and IQ85 were obtained from Yale University Genetic Stock
Center (see http://cgsc.biology.yale.edu for detailed information). The
DRS strain is derived from DR473 and is SecB-deficient; phoA is
deleted from both of these strains (Marrichi et al., 2008). JW3584-1 is
a derivative of MC4100 and is deficient in SecB. IQ85 is also a
derivative of MC4100 but carries a temperature-sensitive mutation at
SecY. JW3584-1, IQ85 and MC4100 maintain the endogenous phoA
gene. The bacterial cells were grown in LB supplemented with
antibiotics as follows: tetracycline for DR473 and DRS, spectinomycin
and streptomycin for IQ85, kanamycin for JW3584-1 and streptomy-
cin for MC4100 (each antibiotic at a final concentration of 50 mg
ml
21). In addition, ampicillin (100 mgm l
21) was added for culture of
the strains transformed with pFLAG constructs.
The E. coli phoA gene with or without the signal peptide region was
inserted into the XhoI/KpnI sites of pFLAG-CTC (Sigma) to create the
recombinant plasmids pFLAG-PhoA (expressing full-length precursor
PhoA) and pFLAG-9PhoA (9PhoA indicates a construct expressing
mature PhoA without the signal peptide). To construct the plasmid
pFLAG-CPAFss-9PhoA, a 93 bp DNA sequence coding for the CPAF
signal peptide (M1-G31, designated CPAFss) was amplified from C.
trachomatis serovar D and inserted into the XhoI/BamHI sites of the
plasmid pBR322-9PhoA. The CPAFss-9PhoA was cloned from the
pBR322 plasmid into pFLAG-CTC vector through the XhoI/KpnI
sites. When the final three plasmids (pFLAG-PhoA, pFLAG-9PhoA
and pFLAG-CPAFss-9PhoA) were expressed in the above wild-type or
mutant bacterial hosts, the FLAG tag in the pFLAG-CTC vector was
added to the C terminus of PhoA.
5-Bromo-4-chloro-3-indolyl phosphate (BCIP) assay. The bac-
terial cells were grown in LB supplemented with the corresponding
selective antibiotics at 37 uC overnight. The overnight cultures were
streaked onto LB agar containing the same selective antibiotics and
50 mg BCIP ml
21 (Sigma) and the plates were incubated at 30 uC for
2 days.
Western blot. The antibody-precipitated samples or bacterial
samples were resolved by using SDS-PAGE and blotted onto
nitrocellulose membranes to detect antigens with specific antibodies,
as described previously (Zhong et al., 2001). The following primary
antibodies were used: mouse mAb 54b against CPAFn (Zhong et al.,
2001) at a final dilution of 1:100; mouse mAb M2 against FLAG tag
(Sigma) at a final dilution of 1:10000; mouse mAb against maltose
binding protein (MBP; Sigma); and rabbit polyclonal antibody
against GroEL (Sigma) at a final dilution of 1:10000. The secondary
antibodies were either goat anti-mouse or anti-rabbit IgG conjugated
with horseradish peroxidase (HRP) at a final dilution of 1:2000. A
standard enhanced chemiluminescent kit was used to visualize the
antibody binding. The antibody-precipitated samples were prepared
as described above. Both whole bacteria and bacterial cell fraction
samples were prepared. The whole bacterial cells were fractionated
into cytoplasmic and periplasmic fractions using a lysozyme-EDTA
method, as described previously (Marrichi et al., 2008) with some
modification. Briefly, a pellet from 10 ml bacterial culture was washed
with ice-cold PBS once and pelleted again by centrifugation at
Sec-dependent secretion of CPAF
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resuspended in 0.5 ml periplasting buffer containing 20 mM Tris/
HCl (pH 7.5), 20% sucrose (EMD Chemicals), 1 mM EDTA
(Sigma), 3 mg lysozyme ml
21 (MP biomedicals). After incubating
on ice for 5 min, 0.5 ml ice-cold distilled water was added to the
suspension and mixed by pipetting up and down. After incubating on
ice for another 5 min, the mixture was pelleted by centrifugation
at 12000 g for 2 min at 4 uC. The periplasmic fraction in the
supernatant was collected to a new tube while the cytoplasmic
proteins in the remaining pellet were resuspended in 1 ml periplasting
buffer. The quality of the fractionated samples was monitored by
immunodetection of both the periplasmic protein MBP and the
cytoplasmic protein GroEL.
Immunofluorescence assay. Chlamydia-infected cells grown on
coverslips were processed for antibody labelling to visualize specific
antigens using an immunofluorescence assay as described previously
(Zhong et al., 2001). Briefly, HeLa cells were infected with L2
organisms at an m.o.i. of 0.5. Eight hours after infection, the culture
medium was replaced with fresh medium containing DMSO, C1
compound or arylomycin C16. At 36 h post-infection, the culture
samples were fixed with 2% paraformaldehyde (Sigma) for 30 min at
room temperature and permeabilized with 2% saponin (Sigma) for
30 min at room temperature. After blocking with DMEM/10% FBS
for 1 h at room temperature, the following primary antibodies were
used: a rabbit antibody against chlamydial EB organisms (unpub-
lished data) at a dilution of 1:2000; a mouse mAb against IncA (clone
no. CB9, mIgG1; unpublished data) at a final dilution of 1:50; a
mouse mAb against CPAF (clone no. IL4A6, mIgG2b; unpublished
data) at a final dilution of 1:50. The primary antibody labelling was
visualized with the secondary antibodies goat anti-mouse IgG2b
conjugated with Cy3 (red), goat anti-mouse IgG1 conjugated with
Cy2 (green) and goat anti-rabbit IgG conjugated with Cy5 (blue). The
triple-labelled samples were observed under a fluorescence micro-
scope (AX-70, Olympus) equipped with a Hamamatsu CCD camera
and the Simple PCI imaging software. The images were acquired one
colour at a time and overlaid with Adobe photoshop software.
RESULTS
The CPAF N-terminal signal peptide is cleaved
during chlamydial infection
We analysed the amino acid sequence of CPAF encoded by
C. trachomatis serovar D for potential secretion signal
peptides using the program SignalP version 3.0 with neural
network (NN) and hidden Markov model (HMM) algo-
rithms (www.expasy.ch). Both NN and HMM algorithms
predict an N-terminal signal peptide in CPAF but with
different cleavage sites. NN predicts a cleavage between
His26 and Ser27 while HMM predicts the cleavage site
between Gly31 and Glu32 (Fig. 1a). To test whether the
predicted N-terminal signal peptide is indeed cleaved
during chlamydial infection and to determine the cleavage
site, we analysed the N-terminal sequence of CPAF purified
from chlamydia-infected cells (Fig. 1b). An anti-CPAFc
mAb was used to affinity purify CPAF and the processed
fragments from chlamydia-infected cells. Bands represent-
ing the precursor and mature full-length CPAF and CPAFn
were excised from the PVDF membrane for N-terminal
sequencing. The precursor CPAF band generated no amino
acid information due to insufficient amounts of protein or
to N-terminal blocking. However, both the mature full-
length CPAF and activated CPAFn bands produced the six
amino acids ESLVCK, which matches residues 32–37 of
CPAF, indicating that a sequence covering residues 1–31
was cleaved from CPAF; this confirms the results predicted
by the HMM algorithm. The cleavage site of Gly31 and
Glu32 is conserved among serovars of C. trachomatis and
Chlamydia muridarum species but is absent in CPAF from
other chlamydial species, suggesting that an alternative
cleavage site may be used by other chlamydial species.
The putative N-terminal signal peptide of CPAF is
able to direct export of PhoA into the bacterial
periplasmic space
Due to a lack of genetic tools for manipulating the
chlamydial genome, we tested the functionality of the
putative CPAF signal peptide using a bacterium-based
phoA gene fusion system. This assay system exploits two
characteristics of PhoA: the enzyme is only active after
translocation into the bacterial periplasm, and the phos-
phatase activity can be conveniently monitored with the
chromogenic substrate BCIP (Marrichi et al., 2008). DNA
Fig. 1. Prediction of CPAF signal peptideand N-terminalsequencing of CPAF. (a) The SignalP 3.0program with both the NN and
HMM algorithms (www.expasy.ch) was used to analyse the precursor CPAF sequence from C. trachomatis serovar D (http://
stdgen.northwestern.edu/). The NN algorithm predicts a signal peptide covering a region from the methionine residue at position
M1 to the histidine residue at position 26 (H26) while the HMM-predicted signal peptide extends to residue G31 (M1–G31). (b)
Endogenous CPAF was immunoprecipitated from chlamydia-infected cell lysates using the mAb 100a; .95% of the precipitate
was resolved by using SDS-PAGE and was transferred onto a PVDF membrane for N-terminal sequencing using the Edman
degradation method. The first six residues derived from the corresponding bands are listed to the right of the gel. The remaining
,5% of the precipitate was also resolved by using SDS-PAGE and analysed via Western blot detection of the N-terminus-
containing CPAF bands with mAb 54b. P, Precursor CPAF; M, mature full-length processed CPAF; n, processed CPAFn.
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residues M1–G31 (designated CPAFss) was fused to the
DNA sequence coding for mature PhoA (designated
9PhoA). The fusion construct was expressed in pFLAG-
CTC which adds a FLAG epitope to the C terminus of
9PhoA. The mature 9PhoA alone construct was used as a
negative control while the precursor full-length PhoA (with
its native N-terminal signal peptide) served as a positive
control. In the presence of BCIP, bacteria expressing either
the precursor PhoA or the CPAFss–9PhoA fusion con-
structs turned blue, whereas bacteria expressing the mature
PhoA alone (9PhoA) remained white, indicating that both
the native PhoA signal peptide and CPAF signal peptides
directed the translocation of PhoA into the periplasm
(Fig. 2a). We used Western blot analysis to monitor the
distribution of PhoA protein in periplasmic and cytosolic
fractions of the bacteria expressing these constructs
(Fig. 2b). Mature PhoA was detected in the periplasm of
bacteria expressing either the precursor PhoA or CPAFss–
9PhoA fusion constructs, while mature PhoA was only
detected in the cytoplasm of the bacteria expressing the
leaderless PhoA. Thus, the CPAF N-terminal signal peptide
is sufficient for directing PhoA across the bacterial inner
membrane.
The CPAF signal peptide-directed translocation of
PhoA requires the Sec-dependent pathway
To further evaluate the role of the Sec-dependent pathway
in CPAF signal peptide-directed translocation of PhoA,
export of mature PhoA encoded by the CPAFss–9PhoA
fusion construct was compared between bacteria with or
without competent secB (Fig. 3) or secY (Fig. 4). When
the CPAFss–9PhoA fusion construct was expressed in the
bacterial strain DR473 that expresses functional SecB, the
colonies turned blue on BCIP plates. In contrast, the DRS
strain that lacks SecB appeared as white colonies when the
same fusion construct was expressed (Fig. 3a), demonstrat-
ing that CPAFss can direct mature PhoA to access the
periplasm in SecB-competent but not SecB-deficient
bacteria. This difference in PhoA export observed in
SecB-competent and SecB-deficient bacteria was confirmed
using a combination of bacterial cell fractionation and
Western blot analysis (Fig. 3b). Mature PhoA was
predominantly detected in the periplasm of SecB-compet-
ent bacteria while the precursor PhoA remained in the
cytosolic fraction of the SecB-deficient bacteria. This was
confirmed by data from another pair of SecB-competent
and -deficient bacteria that carry the endogenous phoA
gene (Fig. 3b, ii and iv). Native PhoA secretion is known to
be independent of SecB (Marrichi et al., 2008); however,
the CPAF leader-peptide-directed export of PhoA was
observed to be dependent on SecB, suggesting that it is the
CPAF leader peptide that renders the SecB-dependence. To
determine whether the CPAF signal peptide-directed
protein export also required SecY, we compared the
translocation of the mature PhoA encoded by the
CPAFss–9PhoA fusion construct between MC4100, which
carries wild-type secY, and IQ85, which expresses a
temperature-sensitive secY allele (Fig. 4). At the permissive
temperature (30 uC), both bacterial strains efficiently
processed the precursor protein and exported mature
PhoA into the periplasmic space. However, at the restric-
tive temperature (42 uC), MC4100 cells were able to
process precursor PhoA into mature PhoA and to export
mature PhoA into the periplasm, while IQ85 cells failed to
do so, suggesting that the CPAF signal peptide-assisted
translocation of mature PhoA is also dependent on SecY.
Fig. 2. The putative N-terminal signal peptide of CPAF is able to
direct translocation of mature PhoA into the bacterial periplasmic
space. (a) Constructs encoding CPAF N-terminal peptide–mature
PhoA fusion protein (CPAFss-9PhoA; 1), mature PhoA (without a
signal peptide, 9PhoA; 2) or full-length PhoA (with its intrinsic signal
peptide; 3) were expressed in E. coli DH5a cells lacking
endogenous PhoA. The transformed bacteria were incubated at
30 6C for 48 h on agar plates supplemented with BCIP. PhoA
translocated into the periplasmic space is able to catalyse BCIP to
produce a blue colour. Note that expression of the constructs
encoding PhoA carrying either thenative orCPAFsignal peptideled
to blue colonies, while the colonies expressing the mature PhoA
alone remained white. (b) Bacterial transformants expressing the
same three constructs were also fractionated into periplasmic (per)
and cytosolic (cyt) fractions; these were separated by SDS-PAGE,
transferred toa PVDF membranebyWesternblot anddetected with
antibodies against a FLAG tag (anti-FLAG, i), MBP (anti-MBP, ii)
and GroEL (anti-GroEL, iii). Note that mature PhoA was secreted
into the periplasm of bacteria expressing either the full-length PhoA
construct or CPAFss-9PhoA construct, while mature PhoA stayed in
the cytoplasm of the bacteria expressing the mature PhoA alone
construct.
Sec-dependent secretion of CPAF
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required for the functionality of the CPAF N-terminal
signal peptide.
CPAF secretion during chlamydial infection
requires the Sec-dependent but not the type III
secretion pathway
Having demonstrated the functionality of the CPAF N-
terminal secretion signal peptide in a heterologous system,
we further tested whether CPAF secretion in chlamydia-
infected cells is also dependent on the general secretory
pathway. To bypass the difficulty in genetic manipula-
tion of the chlamydial genome, we used the compound
arylomycin C16, a lipopeptide-based inhibitor specifically
targeting prokaryotic signal peptidase I (Luo et al., 2009;
Paetzel et al., 2004), to block the chlamydial general
secretory pathway (Fig. 5). Since inhibition of the general
secretory pathway also leads to inhibition of organism
growth, chlamydial infection was allowed for 8 h prior to
the drug treatment and the appropriate drug concentration
was used to permit sufficient levels of protein biosynthesis
for monitoring translocation. We found that arylomycin
C16 at 10 mM completely blocked CPAF secretion into
Fig. 3. The CPAF signal-peptide-directed translocation of mature PhoA is dependent on SecB. (a) The construct coding for the
CPAF signal peptide–mature PhoA fusion protein (CPAFss-9PhoA-FLAG) was transformed into a mutant bacterial strain
deficient in secB (DRS) or its wild-type control strain (DR473). The transformed bacteria were cultured for 48 h at 30 6Co n
agar plates supplemented with BCIP. Note that SecB-deficient bacteria remained white while the wild-type bacteria turned
blue. (b) The parallel bacterial cultures were harvested for fractionation. The presence of PhoA in both the periplasmic (per) and
cytosolic (cyt) fractions was analysed by Western blot as described in the legend to Fig. 2(b). The fusion construct was also
tested in an independent SecB-deficient mutant strain JW3584-1 and its corresponding control, wild-type MC4100. Note that
both SecB-deficient bacterial strains failed to support PhoA export into the periplasm.
Fig. 4. The CPAF signal-peptide-directed
export of mature PhoA also requires SecY. The
construct coding for the CPAF signal peptide–
mature PhoA fusion protein (CPAFss-9PhoA-
FLAG) was transformed into bacterial strains
that carry either a wild-type secY (secY
wt)
or a temperature-sensitive mutant secY allele
(secY
ts). The overnight culture incubated at
30 6C was diluted into fresh medium to reach
OD60050.1. Half of the culture was grown at
30 6C and the other half was grown at 42 6C
for another 4 h. The parallel cultures were
harvested for fractionation. The presence of
PhoA in both the periplasmic (per) and cytosolic
(cyt) fractions was analysed by Western blot as
described in the legend to Fig. 2(b). Note that at
the permissive temperature, bacterial strains
carryingeithersecY
wtorsecY
tsexported mature
PhoA into the periplasm while at the restrictive
temperature, only the secY
wt strain but not the
secY
ts strain exported mature PhoA into the
periplasm.
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Importantly, this treatment did not significantly affect the
inclusion membrane localization of IncA. This is because
secretion of IncA into the inclusion membrane is known to
depend on the type III secretion system and not the general
secretory pathway. Indeed, treatment of the chlamydial
culture with the C1 compound, a small molecule inhibitor
known to block type III secretion in both chlamydia and
other Gram-negative bacteria, led to complete blockage of
IncA localization into the inclusion membrane without
affecting the secretion of CPAF into host cell cytosol
(Fig. 5d–f). Thus, we have demonstrated that CPAF
secretion requires a functional signal peptidase but is
independent of the type III secretion system.
DISCUSSION
CPAF was the first identified secreted protein from
chlamydial organisms and has been characterized exten-
sively, including the recently resolved crystal structure
(Dong et al., 2004a, b, c, 2005; Huang et al., 2008; Zhong
et al., 1999, 2000, 2001). However, its secretion pathway
has remained elusive. Although a putative secretion signal
peptide has been predicted at the N terminus of CPAF, no
experimental evidence has ever been presented to identify
the CPAF secretion pathway(s). Here, we have presented
experimental data that convincingly demonstrate that
CPAF secretion requires the Sec-dependent pathway.
First, the predicted putative N-terminal sequence covering
residues M1–G31 is removed from CPAF in chlamydia-
infected cells, which is consistent with the observation that
CPAF without the signal peptide maintains the tertiary
structure required for its activity (Huang et al., 2008).
Second, the CPAF secretion signal peptide is able to direct
translocation of the mature bacterial phosphatase PhoA
into the bacterial periplasmic space when expressed in a
fusion construct via a transgene, indicating that the CPAF
secretion signal peptide is recognized by bacterial secretion
chaperones and translocons and is cleavable by bacterial
signal peptidases. Third, the CPAF signal peptide-assisted
translocation of PhoA is dependent on both SecB and SecY,
further confirming that both the chaperone and the Sec
translocon are required for the CPAF signal peptide to
exert its function. Finally, and most importantly, CPAF
secretion in chlamydia-infected cells can be blocked by a
small molecule inhibitor arylomycin C16 that specifically
inhibits prokaryotic signal peptidases but cannot be
blocked by the C1 compound that targets the type III
secretion system, demonstrating for the first time that
chlamydial secretion of CPAF is dependent on a functional
signal peptidase. The chlamydial genome does encode a
putative type I signal peptidase (designated CT020; http://
stdgen.northwestern.edu/). The finding that CPAF secre-
tion is not inhibited by the C1 compound is consistent
with previous observations (Betts et al., 2009; Jorgensen &
Valdivia, 2008) and is also in agreement with the
observation that CPAF either full-length or in fragments
cannot be secreted by the type III secretion system of
Yersinia endotuberculosis (our unpublished observations).
Thus, we can conclude that a Sec-dependent, but not a type
III secretion pathway, is required for CPAF secretion.
Previous characterization of CPAF has revealed that CPAF
possesses many common features of bacterial exotoxins.
For example, many exotoxins are processed and some
possess proteolytic activity targeting host proteins to
altering host cell signalling (Bhatnagar & Batra, 2001).
CPAF is a serine protease and can degrade various host
proteins for manipulating host cell signalling pathways
(Zhong et al., 1999, 2000, 2001). CPAF is also processed
into two fragments (Dong et al., 2004a). In the current
study, we have revealed that CPAF, like many bacterial
Fig. 5. CPAF secretion into the cytosol of
chlamydia-infected cells is inhibited by arylo-
mycin C16, an inhibitor targeting prokaryotic
signal peptidase I. HeLa monolayers were
infected with C. trachomatis L2 at an m.o.i. of
0.5 for 8 h. The cultures were treated with
DMSO (a–c), 50 mM C1 compound (d–f; an
inhibitor targeting the Gram-negative bacterial
type III secretion system) or 10 mM C16 (g–i;
an inhibitor targeting the signal peptidase I).
Twenty-four hours after treatment, the cultures
were processed for the immunofluorescence
assay. The processed monolayers were
immuno-labelled with antibodies against chla-
mydia (blue), IncA (green) and CPAF (red).
Note that C1 selectively inhibits secretion of
IncA but not CPAF, while C16 blocks secre-
tion of CPAF but not IncA. White arrows
indicate specific labelling while white arrow-
heads represent possible non-specific signals.
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chlamydial organisms via the general secretory pathway.
The next question is how the periplasmic CPAF is
translocated out of chlamydial organisms and further out
of chlamydial inclusions into host cells. Some bacterial
toxins follow the classical type II secretion pathway by
passing through an outer membrane pore created by the
oligomerization of the GspD to exit the bacterial cells
while others can be released by outer membrane vesicles
(OMVs) (Lee et al., 2008; Mashburn-Warren et al., 2008;
Mashburn-Warren & Whiteley, 2006). The OMV-trapped
toxins can travel far to reach their target cells (Bomberger
et al., 2009). However, it is not known how CPAF passes
through the outer membrane of chlamydial organisms.
Although the chlamydial genome does encode a GspD
homologue, it is unlikely that CPAF exits the chlamydial
organisms through the outer membrane pore. This is
because releasing free CPAF molecules into the lumen
of the inclusion may make it difficult for CPAF to
subsequently translocate into host cells. We propose that
the periplasmic CPAF may use an outer membrane
budding mechanism to exit the chlamydial organisms. In
this way, CPAF molecules are sequestered within the
budding vesicles when the OMVs are still in the lumen of
the chlamydial inclusions. Free CPAF molecules can then
be released into host cells when the CPAF-containing
OMVs fuse with the inclusion membrane or the entire
OMVs bud off the inclusions into host cells. This
hypothesis is supported by the observations that the
chlamydial RB outer membrane can undergo extensive
vesiculation under certain culture conditions (Matsumoto
& Manire, 1970), chlamydial organism-free vesicles are
detected inside the lumen of chlamydial inclusions
(Jorgensen & Valdivia, 2008) and the release of vesicles
from chlamydial inclusions can be induced (Giles et al.,
2006). Efforts are underway to dissect the precise pathways
required for CPAF to enter host cell cytoplasmic space for
targeting host cell proteins.
Regardless of the precise mechanisms by which CPAF exits
the periplasmic space and enters into the host cell cytosol,
the current finding has highlighted the importance of the
general secretory pathway in chlamydial pathogenesis. The
type III secretion system has been found to secrete many
chlamydial substrates/effectors into the inclusion membrane
(Valdivia, 2008) and host cells (Clifton et al., 2004; Valdivia,
2008) and has been extensively studied (Betts et al., 2009).
We have demonstrated that the type II secretion pathway
can also participate in the secretion of chlamydial effectors
into the host cell cytoplasm as suggested previously
(Jorgensen & Valdivia, 2008; Valdivia, 2008). In addition
to CPAF, other putative effectors are also predicted to carry
N-terminal signal peptides, including Tsp (CT441) that is
known to cleave the host cell protein NF-kB (Lad et al.,
2007). It appears that searching for chlamydial effectors that
can be secreted via the Sec-dependent pathway may
represent another productive approach for unravelling
new mechanisms of chlamydial interactions with host cells.
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